Implementation of Suicide Care in Primary Care Cuts Rate of Suicide Attempts
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- Implementation of population-based suicide care (SC) in primary care yields an increase in the rates of safety planning and a reduction in suicide attempts, according to a study published online Oct. 1 in the Annals of Internal Medicine.
Julie Angerhofer Richards, Ph.D., M.P.H., from the Kaiser Permanente Washington Heath Research Institute in Seattle, and colleagues examined the effectiveness of implementing population-based SC in primary care in a secondary analysis of a stepped-wedge, cluster randomized implementation trial. The study compared usual care (UC) and SC periods for adult patients with primary care visits from January 2015 to July 2018. Implementation of depression screening, suicide risk assessment, and safety planning was supported by practice facilitators, electronic medical record clinical decision support, and performance monitoring in the intervention.
Overall, 255,789 patients made 953,402 primary care visits during UC and 228,255 patients made 615,511 visits during SC. The researchers found that the rates of safety planning increased from 39.6 to 46.2 per 10,000 patients comparing UC with SC; in addition, there was a decrease in suicide attempts within 90 days, from 6.57 to 4.93 per 10,000 patients.
"Strategies to improve suicide risk identification and mitigation in primary care implemented alongside a substance care program are effective in reducing suicide attempts," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression
MONDAY, June 16, 2025 -- For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for...
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.